StockData
Health Catalyst, Inc. logo

Health Catalyst, Inc. (HCAT) stock

HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.37−0.01 (-0.72%)

Close on Nov 17, 2026Market cap $103.10MP/E –Yield –

Health Catalyst price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Health Catalyst's price to sales ratio was 0.4× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.3× to 8.9×, with a median of 1.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.2
2025Dec 31, 20250.5×−0.9
2024Dec 31, 20241.4×−0.4
2023Dec 29, 20231.8×−0.3
2022Dec 30, 20222.1×−6.8
2021Dec 31, 20218.9×−1.4
2020Dec 31, 202010.3×+1.7
2019Dec 31, 20198.6×–

More Health Catalyst figures

See a number that looks wrong?